A Clinical Study to Assess the Efficacy and Safety of GSK2402968 in Subjects With Duchenne Muscular Dystrophy

GSK Investigational Site, Budapest

GSK Investigational Site, Koebenhavn Oe

GSK Investigational Site, Leuven

GSK Investigational Site, Marseille

GSK Investigational Site, Milan

GSK Investigational Site, Kiel

GSK Investigational Site, Madrid

GSK Investigational Site, Toulouse

GSK Investigational Site, Göttingen

GSK Investigational Site, Nantes

GSK Investigational Site, Ferrara

GSK Investigational Site, Essen

GSK Investigational Site, Valencia

GSK Investigational Site, Lille

GSK Investigational Site, Paris

GSK Investigational Site, Freiburg im Breisgau

GSK Investigational Site, Munich

GSK Investigational Site, Kaohsiung City

GSK Investigational Site, Messina

GSK Investigational Site, Moscow

GSK Investigational Site, Santiago

GSK Investigational Site, Santiago

GSK Investigational Site, Buenos Aries

GSK Investigational Site, Curitiba

GSK Investigational Site, Porto Alegre

GSK Investigational Site, Ribeirão Preto

GSK Investigational Site, Santo André

GSK Investigational Site, Rio de Janeiro

GSK Investigational Site, São Paulo

GSK Investigational Site, Vancouver

GSK Investigational Site, London

GSK Investigational Site, Montreal

GSK Investigational Site, Santiago

GSK Investigational Site, Prague

GSK Investigational Site, Brno

GSK Investigational Site, Rome

GSK Investigational Site, Rome

GSK Investigational Site, Hyōgo

GSK Investigational Site, Kumamoto

GSK Investigational Site, Saitama

GSK Investigational Site, Tokyo

GSK Investigational Site, Leiden

GSK Investigational Site, Oslo

GSK Investigational Site, Warsaw

GSK Investigational Site, Seoul

GSK Investigational Site, Esplugues de Llobregat. Barcelona

GSK Investigational Site, Ankara